North America Human Microbiome Market to 2025 - Regional Analysis and Forecasts by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Country
- THE3206952
- 152 Pages
- February 2019
- Diagnostic and Biotech
Humans are never alone as they coexist with the diverse microbial species that live within and upon humans. From recent studies it has been very clear that this microbial community is essentially another organ of the body that plays a crucial role in human physiology and disease. Several basic and translational research efforts have been initiated to focus on deciphering mechanisms of microbiome function and how it benefits the human health. Many human medical conditions (like inflammatory bowel diseases and obesity) have been closely associated with or are thought to be influenced by (asthma and diabetes) the composition of the gut microbial community. Many efforts are taken to alter the gut microbiome to eradicate several diseases. Probiotics, prebiotics dietary supplements and foods that contain live microbes have been studied thoroughly to assess their effects on human health.
The Human Microbiome Project of the National Institutes of Health in the United States and related international efforts are defining the varieties of a normal microbiome, studying how changes in the microbiota relate to disease. Large governmental research initiatives including the Human Microbiome Project in the U.S. have accelerated research on the human microbiome.
Also, many companies are designing and developing many microbiome therapies. For instance, Rebiotix Inc. has developed Microbiota Restoration Therapy (MRT) drug platform which is the drug platform for delivering healthy, live, human-derived microbes into a sick patient's intestinal tract to treat disease. Thus, the increasing focus on human microbiome therapies is the prime factor driving the growth of human microbiome market in the coming years.
US is anticipated to lead the adoptions of Human microbiome across the North American region through the forecast period. The application of the human microbiome are beneficial for various treatment areas such as cancer, Inflammatory Bowel Disease (IBD), diabetes, autoimmune diseases and more. To be specific with the applications of the human microbiome, it plays important role in the developments in wide range of diseases and disorders which includes cardiovascular disease, cancer, autoimmune, neurological disorders and more. Therefore, various programs are being organized in the country to grow the awareness of probiotics and prebiotics in order to enhance the human microbiome.
For instance, in February 2018, the 3rd Annual North America Microbiome Congress was held in San Diego, by Kisaco Research that focused on 5 microbiome niches such as the gut, lung, oral, skin and vaginal and provided latest insights on microbiome research, clinical trials and collaborative partnerships.
Thus, owing to the above mentioned factors the market for the human microbiome is likely to grow with a significant growth rate in the coming forecast years.
Exhibit: Mexico Human microbiome Market Revenue and Forecasts to 2027 (US$ Bn)
NORTH AMERICA HUMAN MICROBIOME- MARKET SEGMENTATION
By Product
Probiotics
Foods
Prebiotics
Medical Foods
Diagnostic Device
Drugs
Supplements
NORTH AMERICA HUMAN MICROBIOME- MARKET SEGMENTATION
By Disease
Obesity
Diabetes
Autoimmune Disorders
Cancer
Mental Disorders
Others
NORTH AMERICA HUMAN MICROBIOME- MARKET SEGMENTATION
By Application
Therapeutics
Diagnostics
By Country
U.S.
Canada
Mexico
Companies Mentioned
Enterome
MicroBiome Therapeutics, LLC
Rebiotix Inc.
Yakult Honsha Co., Ltd.
Osel Inc.
Vedanta Biosciences, Inc.
Metabiomics Corporate
Synthetic Biologics, Inc.
DuPont
BiomX Ltd.
PART 1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
PART 2. NORTH AMERICA HUMAN MICROBIOME MARKET - KEY TAKEAWAYS
PART 3. NORTH AMERICA HUMAN MICROBIOME MARKET - MARKET LANDSCAPE
3.1 OVERVIEW
3.2 MARKET SEGMENTATION
3.2.1 North America Human Microbiome Market - By Product
3.2.2 North America Human Microbiome Market - By Disease
3.2.3 North America Human Microbiome Market - By Application
3.2.4 North America Human Microbiome Market - By Country
3.3 PEST ANALYSIS
3.3.1 North America - PEST Analysis
PART 4. NORTH AMERICA HUMAN MICROBIOME MARKET- KEY MARKET DYNAMICS
4.1 KEY MARKET DRIVERS
4.1.1 Growing Prevalence of Chronic Diseases
4.1.2 Increasing Research and Development on Human Microbiome-Based Therapies
4.1.3 Rapid adoption of Metagenomics and Next-Generation Sequencing techniques
4.2 KEY MARKET RESTRAINTS
4.2.1 Stringent Regulatory Framework
4.2.2 Lack of Expertise In Human Microbiome
4.3 KEY MARKET OPPORTUNITIES
4.3.1 Developing Fecal Microbiota Transplantation (FMT) Therapies
4.4 FUTURE TRENDS
4.4.1 Growing Human Microbiome Research in Drug Discovery
4.5 IMPACT ANALYSIS
PART 5. HUMAN MICROBIOME MARKET - NORTH AMERICA ANALYSIS
5.1 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS
5.2 MARKET POSITIONING
5.3 PERFORMANCE OF KEY PLAYERS
Enterome
Yakult Honsha Co., Ltd.
5.4 EXPERT OPINIONS
PART 6. NORTH AMERICA HUMAN MICROBIOME MARKET ANALYSIS - BY PRODUCT
6.1 OVERVIEW
6.2 NORTH AMERICA HUMAN MICROBIOME MARKET, BY PRODUCT, 2017 & 2025 (%)
6.3 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
6.4 FOODS MARKET
6.4.1 Overview
6.4.2 North America Foods Market Revenue and Forecasts to 2025 (US$ Mn)
6.5 MEDICAL FOOD MARKET
6.5.1 Overview
6.5.2 North America Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)
6.6 PROBIOTICS MARKET
6.6.1 Overview
6.6.2 North America Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)
6.7 PREBIOTICS MARKET
6.7.1 Overview
6.7.2 North America Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)
6.8 DRUGS MARKET
6.8.1 Overview
6.8.2 North America Drugs Market Revenue and Forecasts to 2025 (US$ Mn)
6.9 DIAGNOSTIC DEVICES MARKET
6.9.1 Overview
6.9.2 North America Diagnostic Devices Market Revenue and Forecasts to 2025 (US$ Mn)
6.10 SUPPLEMENTS MARKET
6.10.1 Overview
6.10.2 North America Supplements Market Revenue and Forecasts to 2025 (US$ Mn)
PART 7. NORTH AMERICA HUMAN MICROBIOME MARKET ANALYSIS - BY DISEASE
7.1 OVERVIEW
7.2 NORTH AMERICA HUMAN MICROBIOME MARKET, BY DISEASE, 2017 & 2025 (%)
7.3 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
7.4 DIABETES MARKET
7.4.1 Overview
7.4.2 North America Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)
7.5 CANCER MARKET
7.5.1 Overview
7.5.2 North America Cancer Market Revenue and Forecasts to 2025 (US$ Mn)
7.6 AUTOIMMUNE DISORDERS MARKET
7.6.1 Overview
7.6.2 North America Autoimmune Disorders Market Revenue and Forecasts to 2025 (US$ Mn)
7.7 OBESITY MARKET
7.7.1 Overview
7.7.2 North America Obesity Market Revenue and Forecasts to 2025 (US$ Mn)
7.8 MENTAL DISORDERS MARKET
7.8.1 Overview
7.8.2 North America Mental Disorders Market Revenue and Forecasts to 2025 (US$ Mn)
7.9 OTHERS MARKET
7.9.1 Overview
7.9.2 North America Others Market Revenue and Forecasts to 2025 (US$ Mn)
PART 8. NORTH AMERICA HUMAN MICROBIOME MARKET ANALYSIS - BY APPLICATION
8.1 OVERVIEW
8.2 NORTH AMERICA HUMAN MICROBIOME MARKET, BY APPLICATION, 2017 & 2025 (%)
8.3 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
8.4 DIAGNOSTICS MARKET
8.4.1 Overview
8.4.2 North America Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)
8.5 THERAPEUTICS MARKET
8.5.1 Overview
8.5.2 North America Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)
PART 9. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025
9.1 OVERVIEW
9.2 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.3 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
9.4 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
9.5 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
9.6 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
9.7 US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.7.1 US Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.7.2 US Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.7.3 US Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.7.4 US Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.8 CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.8.1 Canada Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.8.2 Canada Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.8.3 Canada Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.8.4 Canada Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.9 MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.9.1 Mexico Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.9.2 Mexico Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.9.3 Mexico Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.9.4 Mexico Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
PART 10. HUMAN MICROBIOME MARKET -INDUSTRY LANDSCAPE
10.1 OVERVIEW
10.2 GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018
10.3 ORGANIC GROWTH STRATEGIES
10.3.1 Overview
10.3.2 Product Launch & Approvals
10.3.3 Expansion
10.3.4 Patent and license
10.4 INORGANIC GROWTH STRATEGIES
10.4.1 Overview
10.4.2 Acquisitions
10.4.3 Partnerships, Collaborations & Agreements
10.4.4 Joint Ventures
PART 11. HUMAN MICROBIOME MARKET-KEY COMPANY PROFILES
11.1 ENTEROME
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 MICROBIOME THERAPEUTICS, LLC
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Information
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 REBIOTIX INC.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 YAKULT HONSHA CO., LTD.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 OSEL INC.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 Swot Analysis
11.5.6 Key Developments
11.6 VEDANTA BIOSCIENCES, INC.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Information
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 METABIOMICS CORPORATE
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 SYNTHETIC BIOLOGICS, INC.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Information
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 DUPONT
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 BIOMX
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Information
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
PART 12. APPENDIX
12.1 ABOUT THE INSIGHT PARTNERS
12.2 GLOSSARY OF TERMS
12.3 METHODOLOGY
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research
LIST OF TABLES
TABLE 1. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 2. NORTH AMERICAHUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 3. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 4. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 5. NORTH AMERICAHUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 6. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 7. US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 8. US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 9. US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 10. CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 11. CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 12. CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 13. MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 14. MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 15. MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 16. RECENT PRODUCT LAUNCHES & APPROVALS IN THE HUMAN MICROBIOME MARKET
TABLE 17. RECENT EXPANSIONS IN THE HUMAN MICROBIOME MARKET
TABLE 18. PATENT AND LICENSE ORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET
TABLE 19. RECENT ACQUISITIONS IN THE HUMAN MICROBIOME MARKET
TABLE 20. RECENT PARTNERSHIPS & COLLABORATIONS IN THE HUMAN MICROBIOME MARKET
TABLE 21. JOINT VENTURES INORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET
TABLE 22. GLOSSARY OF TERMS, HUMAN MICROBIOME MARKET
LIST OF FIGURES
FIGURE 1. US HUMAN MICROBIOME MARKET, REVENUE (US$ MN), BY COUNTRIES 2018 & 2025
FIGURE 2. NORTH AMERICA HUMAN MICROBIOME MARKET BY PRODUCT, MARKET SHARE (%), 2017
FIGURE 3. NORTH AMERICA HUMAN MICROBIOME MARKET BY DISEASE, MARKET SHARE (%), 2017
FIGURE 4. NORTH AMERICA HUMAN MICROBIOME MARKET BY APPLICATION, MARKET SHARE (%), 2017
FIGURE 5. HUMAN MICROBIOME MARKET SEGMENTATION
FIGURE 6. HUMAN MICROBIOME SEGMENTATION, BY REGION
FIGURE 7. NORTH AMERICA PEST ANALYSIS
FIGURE 8. HUMAN MICROBIOME MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS
FIGURE 9. NORTH AMERICA HUMAN MICROBIOME MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2025
FIGURE 10. NORTH AMERICA HUMAN MICROBIOME MARKET, BY PRODUCT, 2017 & 2025 (%)
FIGURE 11. NORTH AMERICA FOODS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 12. NORTH AMERICA MEDICAL FOOD MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 13. NORTH AMERICA PROBIOTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 14. NORTH AMERICA PREBIOTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 15. NORTH AMERICA DRUGS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 16. NORTH AMERICA DIAGNOSTIC DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 17. NORTH AMERICA SUPPLEMENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 18. NORTH AMERICA HUMAN MICROBIOME MARKET BY DISEASE, 2017 & 2025 (%)
FIGURE 19. NORTH AMERICA DIABETES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 20. NORTH AMERICA CANCER MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 21. NORTH AMERICA AUTOIMMUNE DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 22. NORTH AMERICA OBESITY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 23. NORTH AMERICA MENTAL DISORDERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 24. NORTH AMERICA OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 25. NORTH AMERICA HUMAN MICROBIOME MARKET BY APPLICATION, 2017 & 2025 (%)
FIGURE 26. NORTH AMERICA DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 27. NORTH AMERICA THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 28. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN)
FIGURE 29. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 30. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
FIGURE 31. US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 32. CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 33. MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 34. GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018
FIGURE 35. ORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018
FIGURE 36. INORGANIC GROWTH STRATEGIES IN THE ENDOSCOPY DEVICE MARKET, 2015-2018
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
